# A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)

> **NCT00697255** · PHASE2 · TERMINATED · sponsor: **Organon and Co** · enrollment: 8 (actual)

## Conditions studied

- Ovulation Induction

## Interventions

- **DRUG:** corifollitropin alfa
- **BIOLOGICAL:** recombinant Follicle Stimulating Hormone (recFSH)
- **BIOLOGICAL:** human Chorion Gonadotropin (hCG)
- **BIOLOGICAL:** hCG Bolus injection

## Key facts

- **NCT ID:** NCT00697255
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-05-15
- **Primary completion:** 2008-04-03
- **Final completion:** 2008-05-15
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00697255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00697255, "A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00697255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*